Work

An ACT1 Mutation Selectively Abolishes Interleukin-17 Responses in Humans with Chronic Mucocutaneous Candidiasis

Year: 2013

Type: article

Source: Immunity

DOI: 10.1016/j.immuni.2013.09.002

Authors: Bertrand Boisson, Chenhui Wang, Vincent Pedergnana, Ling Wu, Sophie Cypowyj, Michel Rybojad, Aziz Belkadi, Capucine Picard, Laurent Abel, Claire Fieschi, Anne Puel, Xiaoxia Li, Jean-Laurent Casanova

Institutions: Rockefeller University, Cleveland Clinic, Inserm, Sorbonne Paris Cité, Human Genetic of Infectious Diseases, Institut des Maladies Génétiques Imagine, Université Paris Descartes, Hôpital Saint-Louis, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Université Paris Diderot

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: St. Giles Foundation, AXA Research Fund, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Center for Research Resources, National Center for Advancing Translational Sciences

Awards: G1208778535, G1436032867, G1762593819, G1842643373, Molecular and Cellular Mechanisms of IL-17 Signaling, G35364023, Clinical and Translational Science Institute, G798719865, G9000084493, Immunology Training Program-Predoctoral

OpenAlex ID: W1998541797

FWCI: 12.42

Cites: 78

Cited by: 294

Related to: 10